Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
600511.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+18%
0.71
vs 0.6
Q1.23
+10%
0.55
vs 0.5
Q2.23
+16%
0.76
vs 0.65
Q3.23
-17%
0.63
vs 0.76
Q4.23
+28%
0.91
vs 0.71
Q1.24
+11%
0.61
vs 0.55
Q2.24
-5%
0.72
vs 0.76
Q3.24
+1%
0.64
vs 0.63
Q4.24
-24%
0.69
vs 0.91
Q1.25
0%
0.61
vs 0.61
Sales Growth
YoY
Current
Estimates
Q1.23
+2%
11.2B vs 11.1B
Q2.23
+18%
12.9B vs 10.9B
Q3.23
-1%
12.4B vs 12.5B
Q4.23
+20%
13.1B vs 11B
Q1.24
+8%
12.1B vs 11.2B
Q2.24
-2%
12.6B vs 12.9B
Q3.24
+7%
13.3B vs 12.4B
Q4.24
-4%
12.6B vs 13.1B
Q1.25
+5%
12.7B vs 12.1B
Q2.25
+1%
12.8B vs 12.6B
Return on Equity
QoQ
Q2.23
+4%
0.04
vs 0.03
Q3.23
+3%
0.03
vs 0.04
Q4.23
+4%
0.04
vs 0.03
Q1.24
+3%
0.03
vs 0.04
Q2.24
+3%
0.03
vs 0.03
Q3.24
+3%
0.03
vs 0.03
Q4.24
+3%
0.03
vs 0.03
Q1.25
+3%
0.03
vs 0.03
Institutionnal Ownership
Quote Panel
Key Metrics
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
SHH
0.14Â ( 0.48%)
Relative Strenght
Volume Buzz
46%
Earning Acce
No
Dist 52w H.
22%Forecast
342%2026-Revenue
392%2026-EPS
427%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
600511.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 600511.SS compares to sector?